Gene expression profiling in rat liver treated with compounds inducing phospholipidosis

Area of Science:

• Toxicology
• Genomics
• Drug-induced liver injury

Background:

• Hepatic phospholipidosis is a drug-induced liver condition.
• Accurate diagnosis and prediction of this toxicity are crucial for patient safety.
• Current diagnostic methods may have limitations.

Purpose of the Study:

• To identify a gene expression biomarker for diagnosing drug-induced hepatic phospholipidosis.
• To evaluate the utility of toxicogenomics in predicting this liver toxicity.
• To differentiate between typical and atypical phospholipidosis-inducing drugs.

Main Methods:

• Construction of a large-scale rat liver transcriptome database.
• Extraction of 78 probe sets from drug-treated rat liver data.
• Application of Principal Component Analysis (PCA) for data analysis.

Main Results:

• PCA using 78 probe sets clearly separated dose- and time-dependent clusters.
• Six drugs falsely negative by histopathology were identified as positive by PCA.
• Eight drugs with phospholipidosis-like changes were distinguished from typical inducers.
• Gene expression predicted phospholipidosis induction 24 hours after single drug administration.

Conclusions:

• The identified 78 probe sets are potentially useful for diagnosing phospholipidosis.
• Toxicogenomics offers a promising approach for predicting drug-induced liver toxicity.
• This method enhances the accuracy of phospholipidosis diagnosis and prediction.